About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 827534, 5 pages
http://dx.doi.org/10.1155/2012/827534
Research Article

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients

1Washington Cancer Institute, Washington, DC 20010, USA
2MedStar Health Research Institute, Washington, DC 20010, USA

Received 16 April 2012; Accepted 1 May 2012

Academic Editor: Yan Li

Copyright © 2012 Lana Bijelic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Sugarbaker, “Epithelial appendiceal neoplasms,” Cancer Journal, vol. 15, no. 3, pp. 225–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Maggiori and D. Elias, “Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends,” European Journal of Surgical Oncology, vol. 36, no. 7, pp. 599–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. T. D. Yan, M. Deraco, D. Baratti et al., “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience,” Journal of Clinical Oncology, vol. 27, no. 36, pp. 6237–6242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. C. Chua, I. Al-Alem, A. Saxena, W. Liauw, and D. L. Morris, “Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients,” Annals of Surgical Oncology, vol. 18, no. 6, pp. 1540–1546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. D. Yan, E. A. Brun, C. A. Cerruto, N. Haveric, D. Chang, and P. H. Sugarbaker, “Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma,” Annals of Surgical Oncology, vol. 14, no. 1, pp. 41–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Bijelic, T. D. Yan, and P. H. Sugarbaker, “Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2281–2288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. T. D. Yan, L. Bijelic, and P. H. Sugarbaker, “Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2289–2299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Baratti, S. Kusamura, A. D. Cabras, P. Dileo, B. Laterza, and M. Deraco, “Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC),” Annals of Surgical Oncology, vol. 16, no. 2, pp. 463–472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Sarosy, B. Leyland-Jones, P. Soochan, and B. D. Cheson, “The systemic administration of intravenous melphalan,” Journal of Clinical Oncology, vol. 6, no. 11, pp. 1768–1782, 1988. View at Scopus
  10. M. Urano and C. C. Ling, “Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro,” International Journal of Hyperthermia, vol. 18, no. 4, pp. 307–315, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Testori, C. Verhoef, H. M. Kroon, et al., “Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion,” Journal of Surgical Oncology, vol. 104, no. 4, pp. 397–404, 2011. View at Publisher · View at Google Scholar
  12. O. Glehen, O. A. Stuart, F. Mohamed, and P. H. Sugarbaker, “Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model,” Cancer Chemotherapy and Pharmacology, vol. 54, no. 1, pp. 79–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. P. H. Sugarbaker, “Peritonectomy procedures,” Annals of Surgery, vol. 221, no. 1, pp. 29–42, 1995. View at Scopus
  14. A. D. Stephens, R. Alderman, D. Chang et al., “Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique,” Annals of Surgical Oncology, vol. 6, no. 8, pp. 790–796, 1999. View at Scopus
  15. A. Norda, U. Loos, M. Sastry, J. Goehl, and W. Hohenberger, “Pharmacokinetics of melphalan in isolated limb perfusion,” Cancer Chemotherapy and Pharmacology, vol. 43, no. 1, pp. 35–42, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. R. L. Dedrick and M. F. Flessner, “Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure,” Journal of the National Cancer Institute, vol. 89, no. 7, pp. 480–487, 1997. View at Scopus
  17. S. B. Howell, C. E. Pfeifle, and R. A. Olshen, “Intraperitoneal chemotherapy with Melphalan,” Annals of Internal Medicine, vol. 101, no. 1, pp. 14–18, 1984. View at Scopus
  18. P. H. Sugarbaker, J. T. Mora, P. Carmignani, O. A. Stuart, and D. Yoo, “Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy,” Oncologist, vol. 10, no. 2, pp. 112–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. D. Yan, L. Zappa, G. Edwards, R. Alderman, C. E. Marquardt, and P. H. Sugarbaker, “Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-Appendiceal peritoneal carcinomatosis from a prospective database,” Journal of Surgical Oncology, vol. 96, no. 2, pp. 102–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Van der Speeten, O. A. Stuart, D. Chang, H. Mahteme, and P. H. Sugarbaker, “Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis,” Cancer Chemotherapy and Pharmacology, vol. 68, no. 1, pp. 147–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. H. Sugarbaker, K. Van der Speeten, O. Anthony Stuart, and D. Chang, “Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis,” European Journal of Surgical Oncology, vol. 37, no. 8, pp. 719–726, 2011. View at Publisher · View at Google Scholar · View at Scopus